BRPI9908914B8 - composto de ferro-dextrana para uso como um componente em uma composiÇço terapÊutica, para profilaxia ou tratamento de deficiÊncia de ferro; processo para a produÇço do referido composto de ferro-dextrana e uso do referido composto para preparaÇço de uma composiÇço terapÊutica parenteralmente administrÁvel. - Google Patents
composto de ferro-dextrana para uso como um componente em uma composiÇço terapÊutica, para profilaxia ou tratamento de deficiÊncia de ferro; processo para a produÇço do referido composto de ferro-dextrana e uso do referido composto para preparaÇço de uma composiÇço terapÊutica parenteralmente administrÁvel.Info
- Publication number
- BRPI9908914B8 BRPI9908914B8 BRPI9908914A BRPI9908914B8 BR PI9908914 B8 BRPI9908914 B8 BR PI9908914B8 BR PI9908914 A BRPI9908914 A BR PI9908914A BR PI9908914 B8 BRPI9908914 B8 BR PI9908914B8
- Authority
- BR
- Brazil
- Prior art keywords
- iron
- compound
- therapeutic composition
- dextran
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK199800420A DK172860B1 (da) | 1998-03-25 | 1998-03-25 | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
PCT/DK1999/000160 WO1999048533A1 (en) | 1998-03-25 | 1999-03-24 | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI9908914A BRPI9908914A (pt) | 2000-11-21 |
BRPI9908914B1 BRPI9908914B1 (pt) | 2012-06-12 |
BRPI9908914B8 true BRPI9908914B8 (pt) | 2021-07-06 |
Family
ID=8093321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9908914 BRPI9908914B8 (pt) | 1998-03-25 | 1999-03-24 | composto de ferro-dextrana para uso como um componente em uma composiÇço terapÊutica, para profilaxia ou tratamento de deficiÊncia de ferro; processo para a produÇço do referido composto de ferro-dextrana e uso do referido composto para preparaÇço de uma composiÇço terapÊutica parenteralmente administrÁvel. |
Country Status (28)
Country | Link |
---|---|
US (1) | US6291440B1 (pt) |
EP (1) | EP1066056B2 (pt) |
JP (1) | JP4558198B2 (pt) |
KR (1) | KR100612071B1 (pt) |
CN (1) | CN1147322C (pt) |
AR (1) | AR015738A1 (pt) |
AT (1) | ATE220560T1 (pt) |
AU (1) | AU740432B2 (pt) |
BR (1) | BRPI9908914B8 (pt) |
CA (1) | CA2322633C (pt) |
CZ (1) | CZ300823B6 (pt) |
DE (1) | DE69902154T3 (pt) |
DK (2) | DK172860B1 (pt) |
EA (1) | EA003427B1 (pt) |
ES (1) | ES2180279T5 (pt) |
HK (1) | HK1033426A1 (pt) |
HU (1) | HU228483B1 (pt) |
ID (1) | ID26778A (pt) |
NO (1) | NO329591B1 (pt) |
NZ (1) | NZ505983A (pt) |
PL (1) | PL195582B1 (pt) |
PT (1) | PT1066056E (pt) |
SI (1) | SI1066056T2 (pt) |
SK (1) | SK284499B6 (pt) |
TR (1) | TR200002733T2 (pt) |
UA (1) | UA70939C2 (pt) |
WO (1) | WO1999048533A1 (pt) |
ZA (1) | ZA200004016B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
DE60043188D1 (de) * | 1999-04-09 | 2009-12-03 | Amag Pharmaceuticals Inc | Hitzebeständige umhüllte kolloidale eisenoxide |
KR20020003344A (ko) * | 2001-12-17 | 2002-01-12 | 유형선 | 철분 보급제 경구 투여 제제 조성물 |
BR0308773A (pt) * | 2002-04-09 | 2005-02-09 | Pharmacosmos Holding As | Compostos de dextrina de ferro para tratamento de anemia por deficiência de ferro |
DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US20060116349A1 (en) * | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
DE102004031181A1 (de) * | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
ITMO20050056A1 (it) * | 2005-03-15 | 2006-09-16 | Biofer Spa | Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi. |
EP1757299A1 (de) | 2005-08-25 | 2007-02-28 | Vifor (International) Ag | Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung |
EP2626074A1 (en) | 2006-01-06 | 2013-08-14 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
EP1947120A1 (de) * | 2007-01-19 | 2008-07-23 | Vifor (International) Ag | Eisen-Kohlenhydrat-Komplex-Verbindungen |
EP1997833A1 (de) * | 2007-05-29 | 2008-12-03 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
CN101585887B (zh) * | 2008-05-22 | 2011-12-14 | 中国科学院过程工程研究所 | 应用纳滤技术对右旋糖酐铁络合物水溶液进行脱盐和浓缩的方法 |
EP3156075B1 (en) | 2009-03-25 | 2020-10-14 | Pharmacosmos Holding A/S | An oligosaccharide and a process for preparation thereof |
CN101967205B (zh) * | 2010-10-12 | 2013-04-17 | 滨州学院 | 一种β-葡聚糖铁复合物及其制备方法 |
EP2537866A1 (en) | 2011-06-21 | 2012-12-26 | Serumwerk Bernburg AG | Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof |
PL398814A1 (pl) | 2012-04-16 | 2013-10-28 | Uniwersytet Jagiellonski | Zastosowanie pochodnych dekstranu do przeciwdzialania lub leczenia niedokrwistosci |
US10172882B2 (en) | 2014-06-22 | 2019-01-08 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
HUE045092T2 (hu) * | 2014-10-27 | 2019-12-30 | Pharmacosmos Holding As | Vérszegénység kezelése vagy megelõzése vemhes nem-humán emlõsökben és utódaikban |
JP7426927B2 (ja) | 2017-09-11 | 2024-02-02 | ファーマコスモス ホールディング エー/エス | 治療的使用のための鉄錯体化合 |
CN109646454A (zh) * | 2018-12-29 | 2019-04-19 | 博瑞生物医药(苏州)股份有限公司 | 异麦芽糖酐铁1000的制备方法 |
CN110183548B (zh) * | 2019-06-28 | 2021-05-18 | 瑞普(天津)生物药业有限公司 | 一种低分子葡聚糖铁的制备方法及其应用 |
BR112024002150A2 (pt) | 2021-08-03 | 2024-04-30 | Pharmacosmos Holding As | Compostos de complexo de ferro para uso subcutâneo na terapia de deficiência de ferro em animais de companhia |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE24642E (en) | 1959-04-28 | Therapeutic preparations of iron | ||
DK117730A (pt) | ||||
US2885393A (en) | 1956-02-24 | 1959-05-05 | R K Laros Company | Dextran-iron complex and process for making same |
US3093545A (en) | 1960-08-29 | 1963-06-11 | Armour Pharma | Therapeutic iron-dextran preparations |
US3234209A (en) * | 1963-09-13 | 1966-02-08 | Chemicals Inc | Process for making iron hydrogenated dextran |
DE1293144B (de) * | 1964-11-04 | 1969-04-24 | Hausmann Ag Labor | Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid |
GB1183940A (en) | 1966-10-22 | 1970-03-11 | Fisons Pharmaceuticals Ltd | Ferric Hydroxide Complexes |
GB1200902A (en) | 1967-05-13 | 1970-08-05 | Fisons Pharmaceuticals Ltd | Iron-dextran complexes |
CH507993A (de) | 1967-07-13 | 1971-05-31 | Kutnowskie Zakl Farma | Verfahren zur Herstellung von Eisen(III)-komplexverbindungen mit hydriertem Dextran |
DK129353B (da) | 1968-04-29 | 1974-09-30 | Fisons Pharmaceuticals Ltd | Analogifremgangsmåde til fremstilling af et ferrihydroxid-dextranderivatkompleks eller en opløsning deraf. |
US3697502A (en) | 1969-11-03 | 1972-10-10 | Christensen Henry M | Method of making iron dextran-preparations |
GB1562913A (en) * | 1976-06-16 | 1980-03-19 | Fisons Ltd | Fractionating fluid mixtures of dextrans |
DE3422249A1 (de) * | 1984-06-15 | 1985-12-19 | Pfeifer & Langen, 5000 Köln | Wasserloesliches eisendextran und verfahren zu seiner herstellung |
US4827945A (en) | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
US5102652A (en) * | 1986-07-03 | 1992-04-07 | Advanced Magnetics Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
IT1263831B (it) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
RU2093577C1 (ru) * | 1993-11-04 | 1997-10-20 | Государственный институт кровезаменителей и медицинских препаратов | Способ получения декстрана |
GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
US5624668A (en) * | 1995-09-29 | 1997-04-29 | Luitpold Pharmaceuticals, Inc. | Iron dextran formulations |
-
1998
- 1998-03-25 DK DK199800420A patent/DK172860B1/da not_active IP Right Cessation
-
1999
- 1999-03-24 AT AT99908785T patent/ATE220560T1/de active
- 1999-03-24 DK DK99908785T patent/DK1066056T4/da active
- 1999-03-24 CZ CZ20003535A patent/CZ300823B6/cs not_active IP Right Cessation
- 1999-03-24 HU HU0101189A patent/HU228483B1/hu unknown
- 1999-03-24 BR BRPI9908914 patent/BRPI9908914B8/pt not_active IP Right Cessation
- 1999-03-24 AR ARP990101309A patent/AR015738A1/es active IP Right Grant
- 1999-03-24 KR KR1020007010563A patent/KR100612071B1/ko not_active IP Right Cessation
- 1999-03-24 EP EP99908785A patent/EP1066056B2/en not_active Expired - Lifetime
- 1999-03-24 SK SK1409-2000A patent/SK284499B6/sk not_active IP Right Cessation
- 1999-03-24 UA UA2000095459A patent/UA70939C2/uk unknown
- 1999-03-24 PL PL99343164A patent/PL195582B1/pl unknown
- 1999-03-24 SI SI9930103T patent/SI1066056T2/sl unknown
- 1999-03-24 JP JP2000537579A patent/JP4558198B2/ja not_active Expired - Lifetime
- 1999-03-24 CA CA002322633A patent/CA2322633C/en not_active Expired - Fee Related
- 1999-03-24 TR TR2000/02733T patent/TR200002733T2/xx unknown
- 1999-03-24 EA EA200000981A patent/EA003427B1/ru not_active IP Right Cessation
- 1999-03-24 ES ES99908785T patent/ES2180279T5/es not_active Expired - Lifetime
- 1999-03-24 DE DE69902154T patent/DE69902154T3/de not_active Expired - Lifetime
- 1999-03-24 CN CNB998042498A patent/CN1147322C/zh not_active Expired - Lifetime
- 1999-03-24 PT PT99908785T patent/PT1066056E/pt unknown
- 1999-03-24 NZ NZ505983A patent/NZ505983A/xx not_active IP Right Cessation
- 1999-03-24 AU AU28273/99A patent/AU740432B2/en not_active Ceased
- 1999-03-24 ID IDW20001881A patent/ID26778A/id unknown
- 1999-03-24 US US09/509,454 patent/US6291440B1/en not_active Expired - Lifetime
- 1999-03-24 WO PCT/DK1999/000160 patent/WO1999048533A1/en active IP Right Grant
-
2000
- 2000-08-07 ZA ZA200004016A patent/ZA200004016B/xx unknown
- 2000-08-18 NO NO20004151A patent/NO329591B1/no not_active IP Right Cessation
-
2001
- 2001-06-13 HK HK01104034A patent/HK1033426A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI9908914B8 (pt) | composto de ferro-dextrana para uso como um componente em uma composiÇço terapÊutica, para profilaxia ou tratamento de deficiÊncia de ferro; processo para a produÇço do referido composto de ferro-dextrana e uso do referido composto para preparaÇço de uma composiÇço terapÊutica parenteralmente administrÁvel. | |
WO2006068729A3 (en) | Methods and compositions for enhancing iron absorption | |
BRPI0316438C1 (pt) | uso de eritropoietina em doenças cardíacas | |
WO2000074662A3 (en) | Arthritis treatment | |
BRPI0414544A (pt) | 2,4-di-(fenilamino) pirimidinas úteis no tratamento de transtornos proliferativos | |
BRPI0512636A (pt) | adsorvente de fosfato baseado em sulfato de ferro | |
BG108443A (en) | Substituted oxazoliidinones for combinational therapy | |
GB0225474D0 (en) | Therapeutic agents | |
AU1414899A (en) | Surfactant-based antimicrobial compositions and methods for using same | |
PT1459751E (pt) | (s,s)-reboxetina para tratar as enxaquecas | |
CA2376596A1 (en) | Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies | |
CY1109437T1 (el) | ΣΥΝΘΕΣΕΙΣ β-ΓΛΥΚΑΝΩΝ ΚΑΙ ΕΙΔΙΚΩΝ ΑΝΟΣΟΣΦΑΙΡΙΝΩΝ | |
BR0110659A (pt) | Composição farmacêutica, kit, uso de um fator viia em combinação com um fator, xiii, e, métodos para intensificação da formação de coágulo de fibrina em um indivìduo e para tratar de episódios de hemorragia em um indivìduo | |
BR9002334A (pt) | Composicao de condicionamento de tecidos para uso na enxaguadura,e processo para tratar tecidos no ciclo de enxaguadura | |
BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
IL142900A0 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
NO20013493D0 (no) | Anvendelse av neurotrofin samt analoger derav ved behandling av gastrointestinale hypomotilitetslidelser | |
WO2003039453A3 (en) | Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use | |
DK1107795T3 (da) | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis | |
PL368948A1 (en) | Process and composition for treating wood | |
BR0312470A (pt) | Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto | |
EP1038524A4 (en) | L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE | |
DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber | |
BR9900821A (pt) | Processo para melhorar a aparência de uma composição de polimento de piso, composição de veìculo para polimento de pisos, e, uso de ìon cobre divalente. | |
WO2007097810A3 (en) | Treatment for antiphospholipid-syndrome-related pregnancy complications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/06/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/03/99, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 24.03.2019 |